Suzanne M. Garland

40.4k citations

569 papers · 18.9k indexed · 6 hit papers · h-index 65

Microbiology top 0.01%
- Reproductive tract infections research 177
Epidemiology top 0.05%
- Cervical Cancer and HPV Research 311
- Hepatitis B Virus Studies 105
Health top 0.2%
Surgery top 0.2%
- Genital Health and Disease 128
- Colorectal and Anal Carcinomas 40
Otorhinolaryngology top 0.5%
Physiology
- Syphilis Diagnosis and Treatment 46
Molecular Biology
- Molecular Biology Techniques and Applications 43
General Health Professions
- Adolescent Sexual and Reproductive Health 41

Co-authors: Sepehr N. Tabrizi Christopher K. Fairley Catriona S. Bradshaw Xavier Castellsagué Marc Steben Jane S. Hocking Julia Brotherton Dorothy A. Machalek
Cited by: Microbiology Epidemiology Health
Partner nations: Australia United States Canada

In The Last Decade

Suzanne M. Garland

556 papers receiving 18.3k citations

Hit Papers

6 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2020 Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis
2016 Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience
2012 A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines
2012 Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis
2007 Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
2006 High Recurrence Rates of Bacterial Vaginosis over the Course of 12 Months after Oral Metronidazole Therapy and Factors Associated with Recurrence

Peers

Countries citing papers authored by Suzanne M. Garland

Since Specialization

Citations

This map shows the geographic impact of Suzanne M. Garland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne M. Garland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne M. Garland more than expected).

Fields of papers citing papers by Suzanne M. Garland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne M. Garland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne M. Garland. The network helps show where Suzanne M. Garland may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Suzanne M. Garland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Suzanne M. Garland Line = papers co-authored together Suzanne M. Garland links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	An updated understanding of the natural history of cervical human papillomavirus infection—clinical implications Kathrine Dyhr Lycke,Marc Steben,Suzanne M. Garland,Yin Ling Woo,Margaret Cruickshank,Rebecca B. Perkins,Neerja Bhatla,Marc D. Ryser,Patti E. Gravitt,Anne Hammer,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	2025	5
2	Systems serology analysis shows IgG1 and IgG3 memory responses six years after one dose of quadrivalent HPV vaccine Chau Quang,J. L. Anderson,Fiona M. Russell,Rita Reyburn,Tupou Ratu,Evelyn Tuivaga,Rachel Devi,Ian H. Frazer,Suzanne M. Garland,Bruce D. Wines,P. Mark Hogarth,Kim Mulholland,Amy W. Chung,Zheng Quan Toh,Paul V. Licciardi	2025	0
3	Evolving patterns of macrolide and fluoroquinolone resistance in Mycoplasma genitalium: an updated systematic review and meta-analysis Teck-Phui Chua,Lenka A. Vodstrcil,Gerald L. Murray,Erica L. Plummer,Jørgen Skov Jensen,Magnus Unemo,Eric P. F. Chow,Nicola Low,David M. Whiley,Emma L. Sweeney,Jane S. Hocking,Jennifer Danielewski,Suzanne M. Garland,Christopher K. Fairley,Lei Zhang,Catriona S. Bradshaw,Dorothy A. Machalek	2025	7
4	IPVS STATEMENT on HPV vaccination: No longer supply constraints: Towards achieving WHO vaccine targets Suzanne M. Garland,Neerja Bhatla,Yin Ling Woo,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	2024	2
5	Fanconi Anemia Complicated by Cervical Precancer, Vulvar, and Oral Squamous Cell Cancer Tania Day,Lilia Stuart,Yvette Ius,Gholamreza Haqshenas,Suzanne M. Garland,James Scurry	2024	0
6	Seegene Anyplex II assays detect HPV consistently using DNA extracts from different extraction methods Prisha Balgovind,Gerald L. Murray,Dorothy A. Machalek,Suzanne M. Garland,F Azzato,Jee A Hinaut,Jennifer Danielewski,Mónica Molano,Gholamreza Haqshenas	2024	1
7	Does use of anal cytology as a triage test improve the performance of high‐risk human papillomavirus screening in gay and bisexual men for anal cancer prevention? Fengyi Jin,I. Mary Poynten,Richard J. Hillman,Matthew Law,Mónica Molano,Christopher K. Fairley,Suzanne M. Garland,David J. Templeton,Andrew E. Grulich,Jennifer M. Roberts,(unknown)	2024	5
8	Prevotella and Gardnerella Are Associated With Treatment Failure Following First-line Antibiotics for Bacterial Vaginosis Erica L. Plummer,Amelia M Sfameni,Lenka A. Vodstrcil,Jennifer Danielewski,Gerald L. Murray,Glenda Fehler,Christopher K. Fairley,Suzanne M. Garland,Eric P. F. Chow,Jane S. Hocking,Catriona S. Bradshaw	2023	11
9	Real-world impact and effectiveness of the quadrivalent HPV vaccine: an updated systematic literature review Wei Wang,Smita Kothari,Jozica Skufca,Anna R. Giuliano,Karin Sundström,Mari Nygård,Carol E. Koro,Marc Baay,Thomas Verstraeten,Alain Luxembourg,Alfred J. Saah,Suzanne M. Garland	2022	33
10	Australia’s Role in Pneumococcal and Human Papillomavirus Vaccine Evaluation in Asia-Pacific Zheng Quan Toh,Chau Quang,Joseph A. Tooma,Suzanne M. Garland,Kim Mulholland,Paul V. Licciardi	2021	1
11	Prevalence of anal cytological abnormalities and high‐risk human papillomavirus prevalence in kidney transplant recipients: A cross‐sectional study Brenda Rosales,Julian Langton‐Lockton,James Hedley,Alyssa M. Cornall,Jennifer M. Roberts,Suzanne M. Garland,Patrick J. Kelly,Richard J. Hillman,Angela C Webster,(unknown)	2021	3
12	Accuracy of Self-reported Human Papillomavirus Vaccination Status Among Gay and Bisexual Adolescent Males: Cross-sectional Study Eric P. F. Chow,Christopher K. Fairley,Rebecca Wigan,Jane S. Hocking,Suzanne M. Garland,Alyssa M. Cornall,Sepehr N. Tabrizi,Marcus Y. Chen	2021	7
13	Primary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Guideline Silvina Arrossi,Sarah Temin,Suzanne M. Garland,Linda O. Eckert,Neerja Bhatla,Xavier Castellsagué,Sharifa Ezat Alkaff,Tamika Felder,Doudja Hammouda,Ryo Konno,Gilberto Lopes,Emmanuel Mugisha,Raúl Murillo,Isabel C. Scarinci,Margaret Stanley,Vivien Tsu,Cosette M. Wheeler,Isaac F. Adewole,Silvia de Sanjosé	2017	30
14	Polycystic ovarian syndrome: Prevalence and impact on the wellbeing of Australian women aged 16–29 years L. Chitra Varanasi,Asvini K Subasinghe,Yasmin Jayasinghe,Emma T. Callegari,Suzanne M. Garland,Alexandra Gorelik,John D. Wark	2017	29
15	A Composite Cytology–Histology Endpoint Allows a More Accurate Estimate of Anal High-Grade Squamous Intraepithelial Lesion Prevalence Dorothy A. Machalek,I. Mary Poynten,Fengyi Jin,Richard J. Hillman,David J. Templeton,Matthew Law,Jennifer M. Roberts,Sepehr N. Tabrizi,Suzanne M. Garland,Annabelle Farnsworth,Christopher K. Fairley,Andrew E. Grulich	2016	30
16	Targeted Facebook Advertising is a Novel and Effective Method of Recruiting Participants into a Human Papillomavirus Vaccine Effectiveness Study Asvini K Subasinghe,Margaret Nguyen,John D. Wark,Sepehr N. Tabrizi,Suzanne M. Garland	2016	29
17	Improving Vitamin D Status and Related Health in Young Women: The Safe-D study – Part B Marjan Tabesh,Suzanne M. Garland,Alexandra Gorelik,Alison Nankervis,Skye Tamara Maclean,Emma T. Callegari,Shanton Chang,Kayla J. Heffernan,John D. Wark	2016	5
18	Basal Temperature Measurement Using a Multi-Sensor Armband in Australian Young Women: A Comparative Observational Study John D. Wark,Lucy Henningham,Alexandra Gorelik,Yasmin Jayasinghe,Stefanie Hartley,Suzanne M. Garland	2015	9
19	Incident Cervical HPV Infections in Young Women: Transition Probabilities for CIN and Infection Clearance Ralph P. Insinga,Gonzalo Pérez,Cosette M. Wheeler,Laura A. Koutsky,Suzanne M. Garland,Sepp Leodolter,Elmar A. Joura,Daron G. Ferris,Marc Steben,Mauricio Hernández‐Ávila,Darron R. Brown,Elamin H. Elbasha,Nubia Muñóz,Jorma Paavonen,Richard M. Haupt	2011	89
20	Genital Candida Species Detected in Samples from Women in Melbourne, Australia, before and after Treatment with Antibiotics Marie Pirotta,Suzanne M. Garland	2006	93

About Suzanne M. Garland

Suzanne M. Garland is a scholar working on Microbiology, Epidemiology and Microbiology, having authored 569 papers that have together received 18.9k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (311 papers), Reproductive tract infections research (177 papers), Genital Health and Disease (128 papers), Hepatitis B Virus Studies (105 papers), Syphilis Diagnosis and Treatment (46 papers), Molecular Biology Techniques and Applications (43 papers), Adolescent Sexual and Reproductive Health (41 papers) and Colorectal and Anal Carcinomas (40 papers). The work is most often cited by research in Microbiology (5.6k citations), Epidemiology (12.5k citations) and Health (1.3k citations). Suzanne M. Garland has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Sepehr N. Tabrizi, Christopher K. Fairley, Catriona S. Bradshaw, Xavier Castellsagué, Marc Steben, Jane S. Hocking, Julia Brotherton, Dorothy A. Machalek, John T. Schiller and Heather L. Sings.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact